RxDoctor Payments Data

Jacob Reynolds, MD

Ophthalmology · Lubbock, TXNPI 1437507456

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Rxsight Inc at 27.0% of the total. 2025 is the largest year on record at $921, 2.7 times the $346 reported in 2019.

$3,539in general payments, 2019–2025

Across 69 payments — averaging $51.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rxsight Inc$956
  • Alcon$860
  • Johnson & Johnson Surgical Vision, Inc.$716
  • Biotissue Holdings Inc.$193
  • Carl Zeiss Meditec USA, Inc.$150
  • Sight Sciences, Inc.$150
  • plus $515 from 7 others

What the payments were for

  • Food & beverage$3,539100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,539 in reported general payments places this provider in the 65th percentile of 1,355 ophthalmology providers in Texas.

See all ophthalmology providers in Texas →

Medicare billing

Part B allowed, 2024
$314,186
Medicare patients
436
Services billed
1,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost13$7,820
IlevroNepafenac17$6,173
Prednisolone Acetate84$2,482
MoxifloxacinMoxifloxacin Hcl79$1,861
Latanoprost170$1,808
Brimonidine Tartrate15$635
Diclofenac Sodium54$519
Timolol Maleate26$177

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Lubbock

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →